Abstract 4369371: Endocardial to epicardial blood flow ratio predicts the placebo-controlled efficacy of the coronary sinus reducer
Michael Foley(Imperial College Healthcare NHS Trust), Rasha Al‐Lamee(Imperial College Healthcare NHS Trust), Christopher Rajkumar(Imperial College Healthcare NHS Trust), K. Ranil D. de Silva(Imperial College London), Hill Jonathan(Royal Brompton Hospital), Muhammad Mohsin(Imperial College London), Matthew Shun‐Shin(Imperial College London), Ricardo Petraco(Imperial College London), Peter Kellman(National Institutes of Health), Frank E. Harrell(Vanderbilt University Medical Center), James Howard(Imperial College London), Ghada Mikhail(Imperial College Healthcare NHS Trust), Sukhjinder Nijjer(Imperial College London), James Spratt(St George's, University of London), Ramzi Khamis(Imperial College London), Thomas Keeble(Essex Cardiothoracic Centre), Peter O’Kane(Royal Bournemouth Hospital), Fiyyaz Ahmed‐Jushuf(Guy's and St Thomas' NHS Foundation Trust), Tushar Kotecha(Royal Society), Florentina Simader(Imperial College London), Claudia Cosgrove(St George’s University Hospitals NHS Foundation Trust), Dárrel P. Francis(Lung Institute), Danqi Wang(Jiangnan University), Graham Cole(Imperial College Healthcare NHS Trust), John A. Davies(Essex Cardiothoracic Centre), Shayna Chotai(Imperial College Healthcare NHS Trust)
Cited by 0
Related Papers
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
|Circulation|2009|1.1k
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
|The Lancet|2017|1k
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest
|New England Journal of Medicine|2021|979